RANTES is a key chemokine for atherosclerosis, and obesity is associated with progression of atherosclerosis. Substance P (SP) increases glucose uptake and accumulation of lipids in adipocytes, and SP may upregulate RANTES expression. This study investigated the mechanism of RANTES expression by human M1 macrophages stimulated with SP. SP upregulated RANTES protein expression, whereas aprepitant (an NK1R antagonist) blunted this response. Pretreatment of macrophages with BIRB796 (a combined p38g/p38d inhibitor) led to a significant decrease of RANTES expression. Next, we investigated the effect of several NK1R internalization factors on RANTES expression, including GRK2, b-arrestin 2, dynamin, ROCK, and TGFb1. Exposure of macrophages to SP upregulated TGFb1 expression.
Introduction
Obesity is known to be an important risk factor for atherosclerosis [1] . Inflammatory cell recruitment to the intima is an initial step in atherosclerosis, and this process is triggered by chemokines produced by locally activated inflammatory cells. Accumulation of monocyte-derived macrophages in the vessel wall is a hallmark of the atherosclerotic process [2] , and M1 macrophages are the dominant type linked to progression of atherosclerotic disease [3] . Regulated on activation, normal T cell expressed and secreted (RANTES) is produced by M1 macrophages [4] and has been shown to be involved in progression of atherosclerosis [5] . Insulin resistance associated with obesity is a major risk factor for cardiovascular disease. Substance P (SP) enhances insulin resistance at the adipocyte level [6] and increases glucose uptake, resulting in accumulation of lipids in adipocytes [7] . Thus, SP may promote expansion of the fat mass [8] . We previously reported that human visceral adipocytes obtained from subjects with a body mass index (BMI) >30 kg/m 2 show higher production of SP than adipocytes from subjects with a BMI <30 kg/m 2 [9] , suggesting that visceral adipocytes could be a source of SP. Expression of various chemokines is upregulated by SP [10] , and recruitment of inflammatory cells to the vascular intima by chemokines is essential to the development and progression of atherosclerosis. Therefore, SP may represent a link between visceral adipocytes and atherosclerosis. Accordingly, we investigated the mechanisms regulating expression of the atherogenic chemokine/ligand 5 CCL5/RANTES by human M1 macrophages after stimulation with SP.
Neurokinin 1 receptor (NK1R) is the receptor for SP. Recycling and resensitization of NK1R require its internalization in response to SP. Understanding the molecular mechanisms underlying SP-induced internalization of NK1R is important because of the essential role of signal transduction in trafficking of this receptor. During internalization, NK1R signaling not only occurs at the plasma membrane, but also the endosomal membrane. SP-induced internalization of NK1R is mediated by the GTPase dynamin [11, 12] , which is essential for clathrin-mediated endocytosis of NK1R via membrane fission [13] , and NK1R is colocalized with dynamin on the plasma membrane. The b-arrestins also serve as adaptors during SP-mediated internalization of NK1R [14] .
Interestingly, transforming growth factor b1 (TGFb1) has been shown to modulate phosphorylation of NK1R and delay its internalization after activation by SP [15, 16] , with this delay of NK1R internalization leading to marked enhancement of SP-induced cellular signaling [17] . It also has been reported that SP upregulates TGFb1 at the mRNA and protein levels [18] , while TGFb1 downregulates NK1 R gene expression [20] . Various transcription factors, such as specificity protein 1 (Sp1) and CCAAT-enhancer-binding protein b (C/EBPb), induce TGFb1 promoter activity [19, 20] . Therefore, we also investigated the influence of Sp1 and C/EBPb on TGFb1 expression by macrophages in response to SP stimulation.
Materials and methods

Ethics statement
Human peripheral blood samples were obtained from healthy volunteers and this study was approved by the Institutional Review Board of Kumamoto Health Science University. Written informed consent was obtained from all of the volunteers.
Chemicals and reagents
Human recombinant GM-CSF was obtained from Tocris Bioscience, Bristol, UK.
Substance P (Peptide Institute Inc., Osaka, Japan), SB203580 (Wako, Kanagawa, Japan), aprepitant (Cayman Chemical, Ann Arbor, Michigan), PD98059 (Wako), BIRB796 (Axon Medchem, Groningen, Netherlands), U0216 (Promega Corporation, Madison, WI) and mithramycin (Abcam, Cambridge, UK) were employed to investigate the intracellular signaling pathways involved in RANTES production.
The actions of all these reagents are summarized in Table 1 .
Isolation of adherent monocytes from peripheral blood mononuclear cells
Lymphocyte medium for thawing (BBLYMPH1) was obtained from Zen-Bio, Inc.
(Research Triangle Park, NC). Peripheral blood mononuclear cells (PBMCs) were isolated as described previously [21] . Briefly, heparinized blood samples were obtained from nonsmoking healthy volunteers and were diluted 1:1 with pyrogenfree saline. Further, PBMCs were isolated immediately after collection using Lymphoprep gradients (Axis-Shield PoC As, Norway). Then, cells were suspended with BBLYMPH1 and incubated for 3 hrs. For monocyte isolation by plastic adherence, (Sigma-Aldrich), 100 mM/L L-glutamine (Sigma-Aldrich), 100 U/mL penicillin, and 100 mg/mL streptomycin (Sigma-Aldrich).
Induction of macrophages from adherent monocytes
CD14 þ adherent monocytes were seeded at 1 Â 10 6 cells/mL into 12-well tissue culture plates containing RPMI-1640 medium with 10% FCS and 4 mM L-glutamine, and were incubated in the presence of 10 Â 10 3 ng/L recombinant human GM-CSF [23] . On day 1, 3 and 6, the cells were washed and then fresh media containing GM-CSF was added. GM-CSF-dependent macrophages (on 9 day of culture) were utilized as M1 macrophages in this study.
Enzyme-linked immunosorbent assay (ELISA) for RANTES
M1 macrophages were exposed to SP (0, 1 or 5 mM) with or without aprepitant (40 nM) for 6 hr and then protein levels of RANTES in whole-cell lysates were measured by ELISA (R&D Systems, Minneapolis, MN) with an anti-RANTES monoclonal antibody.
Identifying the intracellular signaling pathway for RANTES production
M1 macrophages were pretreated with PD98059 (10 mM), SB203580 (10 mM), BIRB796 (20 mM) or U0126 (60 mM) and then were stimulated for 6 hr with SP (5 mM). Then RANTES protein levels in whole-cell lysates were determined by ELISA (Abcam Inc.).
Extraction of RNA and amplification of RANTES
M1 macrophages (on day 9 of culture) were stimulated with SP (0, 5, 10 or 20 mM) for 6 hr, after which macrophages (1 Â 10 6 cells) were extracted with 1 mL of Isogen RNA kit (Nippon Gene, Toyama, Japan). Total RNA was isolated and precipitated according to the manufacturer's instructions, after which 200 ng of total RNA was reversetranscribed using Oligo dT primer with a PrimeScriptÔ RT reagent Kit (Takara Bio, Shiga, Japan). Then the reverse-transcribed RNA was amplified by the polymerase chain reaction (PCR) using a TaKaRa PCR thermal cycler (Takara Bio, Shiga, Japan). Subsequently, human RANTES was amplified from genomic DNA by the reverse transcriptase-polymerase chain reaction (RT-PCR) using the following primers: 
Luciferase reporter gene assay
The luciferase reporter gene assay was performed as described previously [24] . A RANTES promoter-luciferase reporter plasmid was obtained from Takara Bio Inc.
(Shiga, Japan). Macrophages were transiently transfected with either this plasmid (RANTES) or the empty vector (Mock) using lipofectamine 2000 (Invitrogen, Carlsbad CA) on day 7 of culture [25] . Then macrophages were stimulated for 6 hr with substance P (0, 5, 10 or 20 mM) on day 9 of culture, and cellular extracts were prepared for the luciferase enzyme assay. To determine luciferase activity, 25 mL of Bright-Glo (Promega, Madison, WI) was added to the cells, and luminescence was measured using a TriLux luminescence counter (Perkin-Elmer Life Sciences, Rodgau, Germany) after incubation for 2 min at 37 C. 2.10. Effect of b-arrestin 2 siRNA, GRK2 siRNA, dynasore, Y-27632, or TGFb1/2/3 siRNA on RANTES expression
To determine the role of b-arrestin 2, GRK2, dynamin, ROCK, and TGFb1 in signaling during internalization of NK1R, we investigated the effect of b-arrestin 2 siRNA, GRK2 siRNA, TGFb1/2/3 siRNA, or dynasore (a dynamin inhibitor) or Y-27632 (a ROCK inhibitor) on the expression of RANTES by macrophages after exposure to SP. M1 macrophages transfected with b-arrestin 2 siRNA (50 nM), GRK2 siRNA (50 nM), or TGFb1/2/3 siRNA (50 nM) and macrophages pretreated with dynasore (10 mM) or Y-27632 (10 mM) were stimulated with SP (5 mM) for 6 hr, after which RANTES protein levels were measured by ELISA.
2.11. Effect of mithramycin (a gene-specific Sp1 inhibitor), Sp1 siRNA, C/EBPb siRNA, or TGFb1/2/3 siRNA on expression of TGFb1 or RANTES M1 macrophages (on day 9 of culture) were pretreated with mithramycin (1, 2, or 5 nM) for 6 hr or were transfected with Sp1 siRNA, C/EBPb siRNA, or TGFb1/2/3 siRNA. Then the cells were stimulated with SP (5 mM) for 6 hr, after which latencyassociated peptide (LAP: TGFb1) or RANTES proteins were detected by ELISA.
2.12. Effect of silencing Sp1, C/EBPb, TIF1b, or Fli-1 on RANTES expression by M1 macrophages after stimulation with SP M1 macrophages were transfected with siRNA for Sp1, C/EBPb, TIF1b, or Fli-1 and then were stimulated with SP (5 mM) for 6 hr, after which RANTES protein was determined in whole-cell lysates by ELISA.
Western blotting for TGFb1
M1 macrophages were transfected with siRNA for Sp1, TGFb1/2/3 or C/EBPb.
Then TGFb1 protein production by the transfected cells was detected by western blotting of whole-cell lysates with an anti-mouse monoclonal antibody for TGFb1
(Santa Cruz Biotechnology, Santa Cruz, CA). Whole-cell lysates of M1 macrophages stimulated with human recombinant TNFa (1 ng) for 6 hr were utilized as were stimulated with SP (5 mM) for 6 hr in the presence or absence of aprepitant. Then RANTES protein levels in whole-cell lysates were determined by ELISA. Data were obtained using macrophages from three individuals in each group and represent the mean AE SE. **P < .01 (with Bonferroni's correction).
the positive control. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was also detected by western blotting with an anti-GAPDH antibody (Santa Cruz Biotechnology).
Statistical analysis
Results are expressed as the mean AE SE. Analysis of variance and the t-test for independent means were used to assess differences between multiple groups and differences between two groups, respectively. When the F ratio was found to be significant, mean values were compared by using a post hoc Bonferroni test. A probability (P) value < 0.05 was considered to indicate significance in all analyses.
Results
Stimulation with SP upregulated RANTES production by human M1 macrophages in a concentration-dependent manner compared with untreated control cells. This response was blunted by aprepitant, which is an NK1R antagonist (Fig. 1) . SP caused upregulation of the relative level of RANTES mRNA. In the luciferase reporter gene assay, relative luciferase activity was increased in a concentrationdependent manner by stimulation with SP (Fig. 2) . Interestingly, pretreatment with BIRB796 (a p38g/p38d MAPK inhibitor) significantly decreased the expression of RANTES protein by SP-stimulated macrophages, while neither SB203580
(a p38a/p38b inhibitor) nor PD98059 (an ERK1 inhibitor) affected RANTES expression after SP stimulation. High concentrations of U0126 (an ERK1/2 inhibitor) also had no effect on RANTES production (Fig. 3) . Next, we investigated the role of b-arrestin 2, GRK2, dynamin, ROCK, and TGFb1, which are associated with NK1R internalization and trafficking, in signal transduction associated with RANTES expression. Accordingly, we assessed the effect of b-arrestin 2 siRNA, GRK2 siRNA, or TGFb1/2/3 siRNA, dynasore (a dynamin inhibitor) or Y-27632
(a ROCK inhibitor) on RANTES protein levels after exposure of macrophages to SP. Unexpectedly, b-arrestin 2 siRNA and GRK2 siRNA significantly upregulated RANTES protein production, whereas TGFb1/2/3 siRNA or dynasore attenuated it and Y-27632 had no effect (Fig. 4) . Fig. 3 . Effect of PD98059, SB203580, BIRB796, or U0126 on RANTES production by M1 macrophages stimulated with SP. M1 macrophages day 9 of culture were pretreated with PD98059, SB203580, BIRB796, or U0126 and then were stimulated with SP for 6 hr, after which RANTES protein levels in whole-cell lysates were determined by ELISA. Data were obtained by using cells from three different donors in each group and represent the mean AE SE. **P < .01; *P < .05 (with Bonferroni's correction); N.S., not significant.
Interestingly, silencing of Sp1 significantly enhanced the TGFb1 protein level after exposure of macrophages to SP. We also investigated the effect of mithramycin (an inhibitor of DNA binding by Sp1 family members) on TGFb1 expression after SP stimulation, revealing that inhibition of Sp1 activity by mithramycin significantly increased the TGFb1 protein level in a concentration-dependent manner. Surprisingly, C/EBPb siRNA attenuated TGFb1 production, unlike Sp1 siRNA (Fig. 5 ).
Western blotting also demonstrated the enhancement of TGFb1 expression by Sp1 siRNA or mithramycin, but not by C/EBPb siRNA (Fig. 6 ).
Sp1 siRNA significantly upregulated RANTES protein production by macrophages after exposure to SP compared to untreated control cells. Mithramycin also enhanced the RANTES protein level in a concentration-dependent manner, but silencing of C/EBPb attenuated RANTES production in response to SP (Fig. 7) . We also investigated the role of cross-talk among transcription factors (between Sp1 and C/EBPb, TIF1b, or Fli-1) in RANTES expression by performing double transfection. Compared with TIF1b siRNA or Fli-1 siRNA, we found that C/EBPb siRNA significantly inhibited RANTES production by Sp1 siRNA-transfected macrophages after SP stimulation (Fig. 8) . Fig. 9 displays the proposed protein-protein interactions and signaling pathways addressed in this study.
Discussion
The role of SP in regulating expression of the atherogenic chemokine RANTES by human M1 macrophages is poorly understood. The present study demonstrated that SP upregulated RANTES production by macrophages in a concentration-dependent manner, whereas aprepitant (which inhibits NK1R) blunted this response. SP has previously been shown to increase phosphorylation of p38MAPK and ERK1/2 [26] . However, we found that RANTES production in response to SP stimulation was significantly blunted by BIRB796 (a p38g/p38d inhibitor).
Delayed internalization of NK1R has been shown to enhance its signaling [17] . TGFb1 has been reported to delay SP-induced NK1R internalization [16] , resulting in enhancement of signaling by SP [17] . This study also showed that SP upregulated TGFb1 in macrophages exposed to SP with corresponding enhancement of RANTES protein expression. Interestingly, this enhancement of RANTES production was blunted by TGFb1/2/3 siRNA, which implies that TGFb1 promotes RANTES expression via SP-mediated activation of NK1R. Both transcription factor Sp1 and C/EBPb are known to be promoters of TGFb1 [19, 20] . Therefore, we investigated the effect of Sp1 or C/EBPb on TGFb1 protein production by macrophages stimulated with SP. Unexpectedly, silencing of Sp1 significantly upregulated TGFb1 expression and consequently increased the RANTES protein level in SPstimulated macrophages. Moreover, inhibition of Sp1 activity by mithramycin augmented both TGFb1 and RANTES protein expression in a concentrationdependent manner. Mithramycin is a gene-selective Sp1 inhibitor that binds to GC-rich DNA sequences and displaces Sp1 [27] or modulates Sp1 protein by proteasome-dependent degradation [28] . Several cytokine/chemokine genes are induced or repressed by the transcription factor C/EBPb. In the present study, we found that TGFb1 production was inhibited by C/EBPb siRNA. Activated p38
MAPK regulates C/EBPb via phosphorylation [29] , and this study revealed that SP promoted TGFb1 expression via the NK1R/p38gdMAPK/C/EBPb signaling pathway. Thus, Sp1 and C/EBPb had opposing effects on TGFb1 expression. Cross-talk among transcription factors pathways is extremely complex, with tandem combinations of transcription factors variously being inert or having additive, synergistic, or antagonistic effects. C/EBP-b binds to a number of response elements and forms heteromeric complexes with other transcription factors such as Sp1.
Indeed, the C/EBPb promoter contains a TATA box and binding sites for several transcription factors that regulate C/EBPb mRNA expression, including C/EBPb itself [30] , signal transducer and activator of transcription 3 (STAT3) [31] , and Sp1 [32] . In this study, we demonstrated that C/EBPb siRNA attenuated TGFb1 protein production, whereas it was increased by Sp1 siRNA. Moreover, it has been reported that C/EBPb shows synergistic transcriptional activation of the CYP2D5 P-450 gene with Sp1 [33] . On the other hand, cross-talk between Sp1 and C/EBPb has the opposite effect on induction of tumor suppressor ARF [34] .
The human RANTES promoter region contains a wide variety of transcription factor-binding sites, including sites for CCAAT-enhancer-binding protein (C/EBP) and friend leukemia integration 1 (Fli-1) [35] . Transcriptional intermediary factor 1 beta (TIF1b) was reported to act as a coactivator of C/EBPb [36] . Therefore, we investigated the influence of transcriptional cross-talk between Sp1 and C/EBPb, Fli-1, or TIF1b on RANTES expression by SP-stimulated macrophages. Double transfection of macrophages with Sp1 and C/EBPb siRNA showed a significantly greater inhibitory effect on RANTES production after exposure to SP, compared with transfection of Fli-1 or TIF1b siRNA. Importantly, double transfection of macrophages with Sp1 and C/EBPb siRNA reduced the TGFb1 protein level after exposure to SP. These results suggest that SP1 and C/EBPb are negative and positive regulators of TGFb1 expression, respectively, implying antagonistic cross-talk between these factors.
Obesity is associated with vascular diseases that are often attributed to oxidative stress [37] , and prolonged endoplasmic reticulum stress leads to increased production of reactive oxygen species. C/EBPb is highly expressed by macrophages and regulates NADPH oxidases, which are involved in one of the basic pathogenetic processes of atherosclerosis. The present study revealed that SP promoted TGFb1 expression via the NK1R/p38gd MAPK/C/EBPb signaling pathway, resulting in enhanced production of RANTES through TGFb1-induced delay of NK1R internalization and consequent enhancement of SP signaling. Interestingly, we found that Sp1/C/EBPb cross-talk inhibited the increase of RANTES expression in response to SP, which may imply a link between obesity and regulation of atherogenic RANTES expression via C/EBPb.
In conclusion, the transcription factor Sp1 is involved in cross-talk with C/EBPb and modulates TGFb1 production to negatively regulate RANTES expression by SPstimulated macrophages.
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